A group of scientists from Boston University has found that some new antiviral drugs for hepatitis C could be used to treat post-traumatic stress disorder (PTSD). work published in the American Journal of Epidemiology.
Researchers recruited a group of 254 patients diagnosed with PTSD and hepatitis C between October 1999 and September 2019.
Participants received a combination of approved hepatitis C medications, including glecaprevir and pibrentasvir (GLE/PIB), ledipasvir and sofosbuvir (LDV/SOF), or sofosbuvir and velpatasvir (SOF/VEL). The researchers followed the patients’ symptoms for 8-12 weeks.
Eventually, the team found that the GLE and PIB drugs had the highest levels of effectiveness against PTSD.
“We did our best with the medical registry data, the next important step in this line of studies will be a prospective placebo-controlled study in patients without hepatitis C virus infection,” the scientists said.
Formerly endocrinologist Machekhina announcedhow to eat to live longer